Drug Detail

Information about Regorafenib + Avelumab

Generic Name	Regorafenib + Avelumab
IND
Brand Name (US)
Manufacturer	Bayer, Merck
Drug Type
Delivery	Oral, Intravenous
Approval Status
Indications
Overall Strategy	KIT Protein and immune system
Strategy	Block KIT + Stimulate the immune system
Drug Category	Kit inhibitor + PD-L1 Inhibitor

Links
Trials of this drug
	A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors (REGOMUNE)

Trial results